Navigation Links
US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium
Date:12/14/2009

THE WOODLANDS, Texas, Dec. 14 /PRNewswire/ -- Seven leading cancer physicians and investigators affiliated with US Oncology Research participated in studies that were presented orally at the 2009 San Antonio Breast Cancer Symposium, held Dec. 9-13 at the Henry B. Gonzalez Convention Center in San Antonio, Texas. Fifteen others presented their research in poster presentations during the conference.

Stephen Jones, M.D., medical director for US Oncology Research, co-chair of the US Oncology Breast Cancer Research Committee, and physician at Texas Oncology-Dallas, and Lina Asmar, Ph.D., director of Biostatistics and Medical Writing at US Oncology, were co-authors on a team that presented results at 9:15 a.m. on Thursday, Dec. 10, regarding the five-year analysis of the TEAM (Tamoxifen Exemestane Adjuvant Multinational) prospective randomized phase III trial in hormone sensitive postmenopausal early breast cancer. The study was titled "Five years of exemestane as initial therapy compared to 5 years of tamoxifen followed by exemestane: the TEAM trial, a prospective, randomized, phase III trial in postmenopausal women with hormone-sensitive early breast cancer."

"The TEAM trial is the largest aromatase inhibitor
'/>"/>

SOURCE US Oncology
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
2. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
3. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
4. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
5. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
6. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
7. Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)
8. Pharsight Uses FDA Disease Model to Support Oncology Drug Development
9. US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
10. IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
11. Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... April 20, 2015  Halozyme Therapeutics, Inc. (NASDAQ: ... oncology and drug-delivery therapies, today shared highlights of ... for Cancer Research (AACR) annual meeting. Halozyme also ... randomized Phase 2 study in pancreatic cancer, Study ... the American Society of Clinical Oncology (ASCO). ...
(Date:4/20/2015)... Calif. , April 20, 2015  Published ... positive trends in the ability of Neuraltus ... progression of amyotrophic lateral sclerosis (ALS, also known ... 6-month treatment period. While NP001,s slowing of decline ... study was not statistically significant, clinically meaningful slowing ...
(Date:4/20/2015)... Md. , April 20, 2015  OpGen, ... announced the expansion of its executive management team ... FMI ) executive Kevin Krenitsky , ... as interim chief financial officer. ... leading and managing global diagnostic and biotechnology operations, ...
Breaking Medicine Technology:Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 2Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 3Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 4Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 5Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 2Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 3Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 4Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 5OpGen Appoints Industry Veterans Dr. Kevin Krenitsky as President and Timothy Dec as Interim Chief Financial Officer 2OpGen Appoints Industry Veterans Dr. Kevin Krenitsky as President and Timothy Dec as Interim Chief Financial Officer 3OpGen Appoints Industry Veterans Dr. Kevin Krenitsky as President and Timothy Dec as Interim Chief Financial Officer 4
... RainDance Technologies, Inc. and Ambry Genetics, today ... and commercialization of a comprehensive drug absorption, distribution, ... use on next-generation sequencing (NGS) systems. The announcement ... Toxicology,s 50th Annual Meeting in Washington, D.C. Financial ...
... General Nutrition Company (GNC) today announced a license ... for a line of more than two dozen branded ... will range from heart rate and blood pressure monitors ... The products will be distributed through ...
Cached Medicine Technology:RainDance Technologies and Ambry Genetics Expand Collaboration to Address ADME Analysis 2RainDance Technologies and Ambry Genetics Expand Collaboration to Address ADME Analysis 3RainDance Technologies and Ambry Genetics Expand Collaboration to Address ADME Analysis 4GNC Teams With Sakar International for Branded Health and Wellness Product Line 2GNC Teams With Sakar International for Branded Health and Wellness Product Line 3
(Date:4/20/2015)... Global Lyme Alliance (GLA) announced today that ... the Hyatt Regency Greenwich, raised over $850,000 to fund ... debilitating tick-borne diseases. , “We are extremely grateful ... made this year’s Gala such a success,” said Robert ... education initiatives to ultimately find a cure for ...
(Date:4/20/2015)... OR (PRWEB) April 20, 2015 The NFL ... which type of players to add to their rosters, both ... the field. In this episode of SCI TV , ... Cowboys' recent acquisition of Greg Hardy given increased attention on ... than a year after the Ray Rice scandal brought media ...
(Date:4/20/2015)... Huntsville, AL (PRWEB) April 20, 2015 A ... that when participants were asked to list the top 10 ... when asked to list the 10 most harmful therapies, only ... drugs is that although they may help, their effect is ... consistently,” said Dr. Beck in a recent interview. , “On ...
(Date:4/20/2015)... Washington, DC (PRWEB) April 20, 2015 “Consumers ... using aftershave, or washing their children’s hair will not put ... President and CEO of the National Alliance for Hispanic Health, ... too long the FDA has not had authority to ensure ... are safe nor has FDA had authority to get products ...
(Date:4/20/2015)... 2015 Novatus, a leading provider ... its service level to the growing European market ... and Paris. After a rigorous review process ... of resilience, security and operational expertise, and extensive ... Novatus as we expand our footprint and capabilities ...
Breaking Medicine News(10 mins):Health News:Global Lyme Alliance's “Time for Lyme” Gala Raises Over $850,000 for Tick-Borne Disease Research 2Health News:Global Lyme Alliance's “Time for Lyme” Gala Raises Over $850,000 for Tick-Borne Disease Research 3Health News:Character Concerns in the NFL with Vinnie Iyer on SCI TV 2Health News:Medical Doctor in Huntsville Reveals That Aerobic Exercise Offers Best Results in Fibromyalgia Treatment 2Health News:Statement of National Alliance for Hispanic Health on Senate Introduction of Personal Care Products Safety Act 2Health News:Novatus Expands into European Data Centers 2
... blame, Japanese study finds , , THURSDAY, Dec. 11 (HealthDay News) ... new Japanese study finds. , Those living in multigenerational households ... more likely to be diagnosed with serious heart disease than ... researchers at Osaka University reported in the Dec. 11 online ...
... the age of 90, living well beyond the age of 100 and ... the secret to the fountain of youth. And now, this information is ... ... Wire EON) December 11, 2008 -- Natural Health News Report is ...
... 11 The Susan G. Komen for the Cure(R),Advocacy Alliance ... the next Secretary of Health and Human Services and director ... Alliance noted that,Daschle has long been a leader on health ... years related to breast cancer. , ...
... for Americans to "Tell Their Stories" , ... has indicated that healthcare reform will be a top priority ... offer to serve as health and human services secretary, is ... asking Americans to help with reform efforts by sharing their ...
... Philadelphia, 11 December 2008 Heart failure (HF) clinics ... patients with heart failure, yet there have been no ... clinics. To address this gap, the Quality of ... (HFSA) has developed a consensus statement summarizing the rationale, ...
... aim to strengthen science in selected member states of ... Member States hosting the grantees finance the grants entirely. ... the Czech Republic, Estonia, Hungary, Poland, Portugal and Turkey. ... to five years to help them establish their groups ...
Cached Medicine News:Health News:Crowded Households Raise Women's Heart Risk 2Health News:Crowded Households Raise Women's Heart Risk 3Health News: Anti-Aging Miracle Physicians Have Been Waiting for is Finally Here : Free Book Available From Natural Health News Report Reveals the Secret to Staying Young 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Applauds Selection of Senator Tom Daschle for HHS Secretary, White House Health Reform Czar 2Health News:Hospice Community Encouraged to Respond to Daschle Request to Participate in Information Gathering about Healthcare Concerns 2Health News:New statement outlines essentials of heart failure clinics 2
... The Rotanta 460 family ... extraordinary line that meets ... demands. They feature high ... Their state-of-the-art technology and ...
... 15 centrifuge provides all the ... for today's full-service clinical lab ... a speed up to 15,300 ... spin tubes, plates and rotors ...
... Autocrit Ultra has an uniquely ... a facility in which tubes ... in the same carrying tray. ... built-in magnifier, quiet operation, automatic ...
The Spinchron 15 centrifuge provides all the versatility and high capacity needed for today's full-service clinical lab needs. This centrifuge is available in a nonrefrigerated model with a speed up ...
Medicine Products: